Telemedicine Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Johns Hopkins University Hospital, Baltimore, U.S.
Studies from the United States and Germany describe new findings in cholangiocarcinoma research
September 13th, 2006
Investigators in the United States and Germany have published new cholangiocarcinoma data. Study 1: Examination of bile duct brushings could lead to early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis, warranting further study. "In patients with primary sclerosing cholangitis, there are no reliable markers or imaging modalities to detect malignant changes or early cholangiocarcinoma when curative interventions may still be possible. Clinical features and outcomes were evaluated for 47 patients who underwent 101 endoscopic retrograde cholangiopancreatography (FRCP) procedures with bile duct brushings and...
Source: Telemedicine Business Week (2006-09-13)
|
